secwatch.observer — SEC 8-K summary
======================================

Issuer:     ELITE PHARMACEUTICALS INC /NV/ (ELTP)
CIK:        0001053369
Form:       8-K
Filed at:   2023-06-29T23:59:59+00:00
Accession:  0001493152-23-022959
Event type: earnings
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elite Pharma FY2023 revenue $34.2M (+5.9% YoY); operating profit down $1.4M
---------------------------------------------------------------------------

- FY2023 revenues $34.2M, up 5.9% from prior year; net income $3.6M.
- Operating profit $3.7M, a decrease of $1.4M due to higher R&D and sales-distribution investment.
- Company will host conference call June 30 at 11:30 AM EDT to discuss results.
- Stockholder questions accepted via email prior to the call.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1053369/000149315223022959/0001493152-23-022959-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1053369/000149315223022959/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-022959

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer